Akthelia News Desk
Akthelia receives European Commission Seal of Excellence
Akthelia Pharmaceuticals announce its award of the European Commission Seal of Excellence, a quality recognition by the European Union.
top of page
Akthelia News Desk
- Apr 5
Meet Akthelia Pharmaceuticals at the LSX World Congress 2024
Akthelia Pharmaceuticals is at a pivotal juncture, with a strongly validated and developable lead asset, ready to enter IND-enabling studies
Akthelia News Desk
- Nov 27, 2023
Dr Sonja Srdanović joins Akthelia Pharma as R&D Program Manager for Inflammation and Infection
Dr Sonja Srdanović joins Akthelia Pharma as R&D Program Manager for Inflammation and Infection
Akthelia News Desk
- Oct 30, 2023
Meet Akthelia Pharmaceuticals at Nordic Life Science Days, 2023
Akthelia Pharmaceuticals will attend the Nordic Life Science Days Summit in Copenhagen, 9 - 30 November 2023 REYKJAVIK, Iceland -- 30...
Akthelia News Desk
- Oct 26, 2023
Dr Helga Einarsdóttir joins Akthelia Pharma as R&D Program Manager for Wound Therapeutics
Helga Kristín Einarsdóttir joins Akthelia as R&D Program Manager for Wound Therapeutics.
Akthelia News Desk
- Apr 17, 2023
Akthelia Pharmaceuticals and the University of Iceland Secure a €6M EU Horizon Grant
Akthelia Pharmaceuticals and the University of Iceland Secure a €6M EU Horizon Grant to Combat Antimicrobial Resistance (AMR)
Akthelia News Desk
- Dec 12, 2022
Akthelia Pharmaceuticals is selected to present at the Science4Peace Summit in Stockholm
Akthelia Pharma selected to present at the Science4Peace Summit in Stockholm, Dec 2022
Akthelia News Desk
- Sep 1, 2022
Akthelia Pharmaceuticals Participates in the LSX Leaders Nordic Congress 2022
Akthelia Pharmaceuticals Participates in the LSX Leaders Nordic Congress 2022
Akthelia News Desk
- Jun 29, 2022
Akthelia Pharmaceuticals Announces Second Close of Follow-Up Pre-Seed Equity Round
Akthelia Pharmaceuticals Announces Second Close of Follow-Up Pre-Seed Equity Round
Akthelia News Desk
- Jan 20, 2022
Akthelia Pharmaceuticals Announces Close of Follow-Up Pre-Seed Equity Round
Akthelia Pharma Announce Close of Follow-Up Pre-Seed Equity Round
Akthelia News Desk
- Sep 1, 2021
Dr Steingrímur Stefánsson joins Akthelia Pharma in the role of Senior Scientist
Highly experienced research scientist Dr Steingrímur Stefánsson joins Akthelia to boost R&D capabilities
Akthelia News Desk
- Jun 1, 2021
Akthelia Pharma is awarded a RANNÍS grant for wound healing
RANNÍS, the Icelandic technology fund, has awarded Akthelia Pharma $330,000 for the initial development of its novel wound healing approach.
Akthelia News Desk
- Sep 1, 2020
Akthelia Pharma Announces Close of a Pre-Seed Equity Round
Akthelia Pharma Announces Close of a Pre-Seed Equity Round
Akthelia News Desk
- Jun 15, 2019
Akthelia Pharma is awarded a RANNÍS grant towards a POC of its innate immunity approach
RANNÍS, the Icelandic technology fund, has awarded Akthelia Pharma $330,000 to develop a proof of concept
Akthelia News Desk
- Jan 28, 2019
Akthelia will attend the 2019 ANTIMICROBIAL PEPTIDES GORDON RESEARCH CONFERENCE
Akthelia will attend the 2019 ANTIMICROBIAL PEPTIDES GORDON RESEARCH CONFERENCE
bottom of page